Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHaleon Regulatory News (HLN)

Share Price Information for Haleon (HLN)

Share Price is delayed by 15 minutes
Get Live Data
321.20    0.30 (0.09%)
Bid:
320.40
Ask:
320.50
Spread: 0.10 (0.031%)
Market Cap: £28.42b
HLN Live PriceLast checked at - London Stock Exchange

Intraday Haleon Share Chart

Director/PDMR Shareholding

10 Sep 2024 16:50

RNS Number : 6350D
Haleon PLC
10 September 2024
 

 

Haleon plc

("Haleon" or "the Company")  

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 

 

10 September 2024: Notification and Public Disclosure in accordance with the requirements of The UK Market Abuse Regulation of transactions by Persons Discharging Managerial Responsibilities ("PDMRs").

This notification sets out the details of the grant of Haleon share awards over Ordinary Shares made to PDMRs under the Haleon Performance Share Plan 2023 and Share Value Plan 2023.

The Performance Share Plan (Interim) awards are pro-rated to reflect the date of joining Haleon and subject to continued employment and performance conditions over the performance period ending on 31 December 2026 (vesting in March 2027). Performance targets were disclosed in the 2023 Annual Report and Form 20-F.

The Performance Share Plan (Buyout) awards are subject to continued employment and performance conditions over the performance period as specified below.

The Share Value Plan (Buyout) awards are subject to continued employment.

All awards are subject to malus and clawback provisions.

 

 

Details of the person discharging managerial responsibilities / person closely associated  

 

a)

 

Name

 

Line De Decker

 

 

Reason for the notification  

 

a)

 

Position/status

 

 

Chief Human Resources Officer

b)

 

Initial notification /Amendment 

Initial Notification 

 

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor  

a)

 

Name

 

Haleon plc 

b)

 

LEI

 

549300PSB3WWEODCUP19 

 

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted  

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of £0.01 each

Identification code

GB00BMX86B70

b)

 

Nature of the transaction

 

(i) Grant of a conditional award under the Haleon plc Performance Share Plan (Buyout) subject to performance conditions over the performance period ending on 31 December 2025 (vesting in March 2026).

(ii) Grant of a conditional award under the Haleon plc Performance Share Plan (Buyout) subject to performance conditions over the performance period ending on 31 December 2026 (vesting in March 2027).

(iii) Grant of a conditional award under the Haleon plc Performance Share Plan (Buyout) subject to performance conditions over the performance period ending on 31 December 2026 (vesting in March 2028).

(iv) Grant of a conditional award under the Haleon plc Performance Share Plan (Interim).

 

c)

 

Price(s) and volume(s)

Price(s) 

Volume(s) 

(i)

Nil

176,411

(ii)

Nil

194,052

(iii)

Nil

113,197

(iv)

Nil

160,257

d)

 

Aggregated information

- Aggregated volume 

643,917

- Price 

Nil

e)

 

Date of the transaction

 

10 September 2024

f)

 

Place of the transaction

 

Outside a trading venue

 

 

 

 

Details of the person discharging managerial responsibilities / person closely associated  

 

a)

 

Name

 

Claire Dickson

 

 

Reason for the notification  

 

a)

 

Position/status

 

 

Chief Digital and Technology Officer

b)

 

Initial notification /Amendment 

Initial Notification 

 

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor  

a)

 

Name

 

Haleon plc 

b)

 

LEI

 

549300PSB3WWEODCUP19 

 

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted  

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of £0.01 each

Identification code

GB00BMX86B70

b)

 

Nature of the transaction

 

(i) Grant of a conditional award under the Haleon plc Performance Share Plan (Buyout) subject to performance conditions over the performance period ending on 31 December 2025 (vesting in March 2026).

(ii) Grant of a conditional award under the Haleon plc Performance Share Plan (Buyout) subject to performance conditions over the performance period ending on 31 December 2026 (vesting vest in March 2027).

(iii) Grant of a conditional award under the Haleon plc Share Value Plan (Buyout) vesting in July 2026.

(iv) Grant of a conditional award under the Haleon plc Performance Share Plan (Interim).

 

c)

 

Price(s) and volume(s)

Price(s) 

Volume(s) 

(i)

Nil

122,756

(ii)

Nil

39,886

(iii)

Nil

15,197

(iv)

Nil

117,949

d)

 

Aggregated information

- Aggregated volume 

295,788

- Price 

Nil

e)

 

Date of the transaction

 

10 September 2024

f)

 

Place of the transaction

 

Outside a trading venue

 

 

 

 

Details of the person discharging managerial responsibilities / person closely associated  

 

a)

 

Name

 

Adrian Morris

 

 

Reason for the notification  

 

a)

 

Position/status

 

 

General Counsel

b)

 

Initial notification /Amendment 

Initial Notification 

 

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor  

a)

 

Name

 

Haleon plc 

b)

 

LEI

 

549300PSB3WWEODCUP19 

 

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted  

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of £0.01 each

Identification code

GB00BMX86B70

b)

 

Nature of the transaction

 

(i) Grant of a conditional award under the Haleon plc Performance Share Plan (Buyout) subject to performance conditions over the performance period ending on 31 December 2025 (vesting in March 2026).

(ii) Grant of a conditional award under the Haleon plc Share Value Plan (Buyout) (vesting in September 2027).

(iii) Grant of a conditional award under the Haleon plc Performance Share Plan (Interim).

 

 

c)

 

Price(s) and volume(s)

Price(s) 

Volume(s) 

(i)

Nil

334,025

(ii)

Nil

76,924

(iii)

Nil

192,308

d)

 

Aggregated information

- Aggregated volume 

603,257

- Price 

Nil

e)

 

Date of the transaction

 

10 September 2024

f)

 

Place of the transaction

 

Outside a trading venue

 

 

Amanda Mellor

Company Secretary

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBUGDCGSBDGSG
Date   Source Headline
3rd Apr 20235:30 pmRNSDirector/PDMR Shareholding
23rd Mar 20235:00 pmRNSDirector/PDMR Shareholding
21st Mar 20233:00 pmRNSDirector/PDMR Shareholding
20th Mar 20233:15 pmRNSAnnual Financial Report 2022 and Notice of AGM
13th Mar 20235:00 pmRNSDirector/PDMR Shareholding
9th Mar 20233:30 pmRNSEnvironmental & Social Sustainability Committee
7th Mar 20232:00 pmRNSDirector/PDMR Shareholding
2nd Mar 20237:00 amRNSHaleon Full Year Results 2022
13th Feb 20233:00 pmRNSDirector/PDMR Shareholding
7th Feb 202311:50 amRNSOutcome of audit tender
31st Jan 202312:06 pmRNSBoard changes
17th Jan 202311:07 amRNSDirector/PDMR Shareholding
22nd Dec 20224:00 pmRNSDirector/PDMR Shareholding
13th Dec 202212:58 pmRNSDirector/PDMR Shareholding
11th Nov 202212:58 pmRNSDirector/PDMR Shareholding
10th Nov 20227:00 amRNSQ3 Trading Statement
31st Oct 202212:00 pmRNSExpiration and Results of Exchange Offers
13th Oct 202212:00 pmRNSDirector/PDMR Shareholding
10th Oct 20224:45 pmRNSDirector/PDMR Shareholding
10th Oct 20224:45 pmRNSDirector/PDMR Shareholding
29th Sep 20224:19 pmRNSExchange Offers for Certain Series of Notes
26th Sep 202212:45 pmRNSDirector/PDMR Shareholding
20th Sep 20227:00 amRNS2022 Half Year Results
13th Sep 20224:07 pmRNSChange to HY 2022 results date
1st Sep 202212:00 pmRNSTotal Voting Rights
19th Aug 202210:00 amRNSDirector Declaration
12th Aug 20227:00 amRNSStatement re Zantac
9th Aug 20222:30 pmRNSHolding(s) in Company - Replacement
4th Aug 202212:00 pmRNSHolding(s) in Company
3rd Aug 20223:00 pmRNSReduction of Capital Becomes Effective
3rd Aug 202212:33 pmRNSDirector/PDMR Shareholding
2nd Aug 20222:39 pmRNSDirector/PDMR Shareholding
1st Aug 20221:39 pmRNSTotal Voting Rights
29th Jul 20223:17 pmRNSDirector/PDMR Shareholding
28th Jul 20226:15 pmRNSDirector/PDMR Shareholding
28th Jul 20226:15 pmRNSDirector/PDMR Shareholding
27th Jul 20227:00 amRNSH1 Trading Update - Six Months Ended 30 June 2022
26th Jul 20226:00 pmRNSDirector/PDMR Shareholding
26th Jul 20225:40 pmRNSHolding(s) in Company
26th Jul 20225:35 pmRNSHolding(s) in Company
22nd Jul 202211:15 amRNSAppointment of Joint Corporate Brokers
21st Jul 20225:30 pmRNSDirector/PDMR Shareholding
21st Jul 20224:41 pmRNSSecond Price Monitoring Extn
21st Jul 20224:36 pmRNSPrice Monitoring Extension
20th Jul 20225:45 pmRNSDirector/PDMR Shareholding
20th Jul 20225:45 pmRNSDirector/PDMR Shareholding
20th Jul 20225:45 pmRNSDirector/PDMR Shareholding
19th Jul 202211:30 amRNSHolding(s) in Company
18th Jul 20226:01 pmRNSHolding(s) in Company
18th Jul 20226:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.